Castleark Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-34,885
Closed -$3.97M 317
2022
Q2
$3.97M Sell
34,885
-32,805
-48% -$3.77M 0.21% 112
2022
Q1
$8.77M Buy
67,690
+6,870
+11% +$990K 0.38% 56
2021
Q4
$11M Sell
60,820
-8,715
-13% -$1.51M 0.4% 63
2021
Q3
$10.3M Buy
69,535
+2,750
+4% +$421K 0.39% 66
2021
Q2
$10.1M Buy
+66,785
New +$9.3M 0.34% 76
2019
Q4
Sell
-159,437
Closed -$11.5M 382
2019
Q3
$11.5M Buy
159,437
+15,015
+10% +$1.1M 0.47% 59
2019
Q2
$12.4M Buy
144,422
+12,235
+9% +$994K 0.48% 59
2019
Q1
$10.7M Buy
+132,187
New +$9.9M 0.4% 76
2018
Q1
Sell
-184,260
Closed -$8.94M 428
2017
Q4
$8.94M Sell
184,260
-1,045
-0.6% -$52.7K 0.27% 125
2017
Q3
$9.46M Buy
+185,305
New +$8.88M 0.3% 116
2015
Q3
Sell
-176,700
Closed -$6.66M 395
2015
Q2
$6.66M Sell
176,700
-17,600
-9% -$642K 0.18% 157
2015
Q1
$6.82M Buy
+194,300
New +$6.41M 0.16% 162

Other funds holding OMCL

Castleark Management's OMCL Position: Q3 2022 in Review

Castleark Management sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 34,885 shares — an estimated $3.97M sold.

Castleark Management first reported a position in OMCL in Q1 2015 and held it in 12 quarters. The position peaked at $12.4M in Q2 2019. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

  • Castleark Management reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
  • Castleark Management sold 34,885 Omnicell shares in Q3 2022, an estimated $3.97M.
  • Castleark Management first reported a position in Omnicell in Q1 2015 and held it in 12 quarters.
  • Castleark Management's Omnicell position peaked at $12.4M in Q2 2019.
  • 374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on Castleark Management's 13F filing for Q3 2022, filed 15 Nov 2022.